期刊文献+

基于TRAIL受体热稳定的亲和性定量检测

Affinity Detection and Quantification of Receptors of TRAIL Based on Their Thermostability
原文传递
导出
摘要 目的基于肿瘤坏死因子相关凋亡诱导配体(tumor necrosis factor-related apoptosis-inducing ligand,TRAIL)受体的热稳定性建立其在肿瘤中定量检测的新途径。方法检测胰腺癌细胞AsPC-1和Capan-2內源碱性磷酸酶(alkaline phosphatase,AP)的活性和变性温度。利用AP标记的TRAIL(AP-TRAIL)分别孵育转膜后的死亡受体5(death receptor 5,DR5)融合蛋白(DR5-AP)和经100℃沸水蒸煮去除内源AP活性的胰腺癌细胞系AsPC-1和Capan-2,再与AP的底物Reagent S和Reagent A进行颜色反应,进行细胞受体定量检测和细胞原位受体结合试验。结果胰腺癌细胞系AsPC-1和Capan-2的内源AP在65℃水浴下不能完全失活,阻碍了对TRAIL受体的检测,在沸水蒸煮后其AP活性显著下降,而DR5-AP在沸水中具有热稳定性。AP-TRAIL能够识别并结合高温蒸煮后的胰腺癌细胞AsPC-1和Capan-2表面的受体,AP-TRAIL孵育的读数为2.210±0.393和2.027±0.019。结论 TRAIL受体具有热稳定的性质,它的发现能够为更好的肿瘤诊断、预测及个性化治疗提供新方法。 Objective To develop a way for tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)receptors quantification in cancer via its' thermostability.Methods Endougenous alkaline phosphatase(AP)activity and denaturation temperature of pancreatic cancer cell lines AsPC-1and Capan-2 were detected.Boiling treated recombinant protein death receptor 5(DR5),named DR5-AP,as well as pancreatic cancer cells lines AsPC-1and Capan-2were incubated with AP-tagged TRAIL(AP-TRAIL),and then reacted with Reagent A and Reagent S,the substrate of AP,to quantitive and in site detection of the receptor.Results The endougenous AP activity of pancreatic cancer cells lines AsPC-1and Capan-2could not be totally inactivated by incubated at 65 ℃,thus inhibited the detection of TRAIL receptor,but the activity was dramatically decreased after treated with boiling water,whereas the DR5-AP was thermal stable.The surface receptor of AsPC-1and Capan-2could be recognized and bound by AP-TRAIL after treated at 100℃,the readings were 2.210±0.393 and 2.027±0.019.ConclusionThe TRAIL receptors are thermostable and this may provide a better diagnosis and prognosis of cancer as well as personalize cancer therapy.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2015年第3期449-452,共4页 Journal of Sichuan University(Medical Sciences)
基金 国家高技术研究发展计划(No.2012AA02A305)资助
关键词 肿瘤治疗 TRAIL受体 热稳定性 AP标签 Cancer therapy Receptors of TRAIL Thermostability AP-tag
  • 相关文献

参考文献12

  • 1I)anial NN, Korsmeyer SJ. Cell death: critical control points. Cell, 2004 ;116(2) :205-219.
  • 2JohnstoneRW, Frew AJ, Smylh MJ. The TRAIL apoplotie pathway in e,meer onset, progression and therapy. Nal Rev Cancer, 2008,8 ( l 0) : 782-798.
  • 3Locks|ey RM, Killeen N, Lenardo MJ. The TNF and "I'NF receptor superfamilies-integrating mammalian biology. Cell, 2001;104(4):487 501.
  • 4Akihiro H, Masaki Y, Takahide T, e! al. Receptor acli;'ator of NF-,B (RANK) ligand induces ectodomain sht, dding of RANK in murine RAW26,1.7 macrophages. J lmmunol.2010; 184(5):2442 2448.
  • 5Zhang R, Tan Z, I.iang P. Identification of a novel ligand receptor pair constitutively activaled by ras oncogenes. J Biol ('hem,2000;275(32) :24436-24443.
  • 6Wang M, Tan Z, Zhang R, et al. Interleukin 24 (MI)A 7/ MOB-5) signals through two helerodimeric receptors, I1. 22R1/II.-20R2 and II.-20R1/II.-20R2. j Biol Chem,2002,277 (9) : 7341-7347.
  • 7Baranov K, Volkova (), Chikaev N, el al. A direct anligen binding assay for deteclion of antibodies against native epitopes using alkaline phosphatase-tagged proleins. J lmmunol Methods.2008 ;332( 1 ) =73-81.
  • 8Aruffo A, Stamenkovic I, Melnick M, el al. CT)44 is the principal cell surf,me receptor for hyaluronate. (_Tell, 19!,0; 61 (7) : 1303-1313.
  • 9Flanagan JG, Cheng tiJ. Alkaline phosphatase fusion pr,,teins for molecular characterization and (:lt)ning of receptors and their ligands. Methods Enzymo,200);327:198 210. doi:10. 1016/ S0076 6879(00)27277 7.
  • 10Flanagan JG, Cheng HJ, Feldheim I)A. et al. Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos. Mctlmds l',nzytuol, 2000,a27:19-,35. doi: 10. 1016/S007fi-6879(00)27261 9.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部